SCHEMBL21596793

SCHEMBL21596793

COc1cc(-c2ccccc2)cc2onc(N)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FYN P06241 3/20 0.44
FGFR1 P11362 3/20 0.43
KDR P35968 3/20 0.43
FLT3 P36888 3/20 0.43
MAP4K2 Q12851 3/20 0.43
ROCK1 Q13464 3/20 0.43
AURKB Q96GD4 3/20 0.43
MAP4K4 O95819 2/20 0.43
PDGFRB P09619 2/20 0.43
PIM1 P11309 2/20 0.43
PDGFRA P16234 2/20 0.43
PRKACA P17612 2/20 0.43
LTK P29376 2/20 0.43
GRK5 P34947 2/20 0.43
CDK8 P49336 2/20 0.43
CDK7 P50613 2/20 0.43
CDK9 P50750 2/20 0.43
LIMK1 P53667 2/20 0.43
MAP2K1 Q02750 2/20 0.43
ACVR1 Q04771 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21596867 0.85 KDR (0.56) FYNFGFR1KDRFLT3MAP4K2
SCHEMBL29652439 0.85 KDR (0.56) FYNFGFR1KDRFLT3MAP4K2
SCHEMBL21596901 0.82 NPC1 (0.48) ALDH1A1KDM4EHSD17B10NPC1RAB9A
SCHEMBL29652491 0.82 NPC1 (0.48) ALDH1A1KDM4EHSD17B10NPC1RAB9A
SCHEMBL21596927 0.77 FYN (0.41) FYNFLT3PDGFRBPDGFRAALDH1A1
SCHEMBL21608946 0.75 KAT7 (0.36) FYNFGFR1KDRFLT3MAP4K2
SCHEMBL21596906 0.75 GLRA3 (0.36) FGFR1KDRFLT3MAP4K2ROCK1
SCHEMBL1781983 0.74 KDR (0.50) FYNFGFR1KDRFLT3MAP4K2
SCHEMBL27176094 0.74 HPGD (0.49) ALDH1A1KDM4EHSD17B10MEN1KMT2A
SCHEMBL21609236 0.74 KAT6A (0.66)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062393-A1 Compounds CTXT PTY LTD (AU) 2026-03-05 US disclosed
US-12365655-B2 Compounds CTXT PTY LTD (AU) 2025-07-22 US disclosed
CN-112334466-B Compounds of formula (I) CTXT私人有限公司 2025-05-30 CN disclosed
EP-4335439-A2 COMPOUNDS CTXT PTY LTD (AU) 2024-03-13 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
EP-3810602-A1 COMPOUNDS CTXT Pty Limited (AU) 2021-04-28 EP disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153710-A1 Compounds SLC10A1, ABCB11, PCSK9 FYN 1663/4885FGFR1 972/4885KDR 4509/4885
US-20200039945-A1 Compounds SLC10A1, ABCB11, PCSK9 FYN 1670/4885FGFR1 974/4885KDR 4505/4885
US-20260062393-A1 Compounds SCN2B, ABCB11, SCN1B FYN 1783/4885FGFR1 241/4885KDR 1022/4885
US-12365655-B2 Compounds SLC10A1, ABCB11, PCSK9 FYN 1670/4885FGFR1 974/4885KDR 4505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.